Evidence map›Paper›PMID 28615219›Full record

ArticleBlood2017

ZFP521 regulates murine hematopoietic stem cell function and facilitates MLL-AF9 leukemogenesis in mouse and human cells.

Brian S Garrison, Adrian P Rybak, Isabel Beerman, Balthasar Heesters, Francois E Mercier, David T Scadden, David Bryder, Roland Baron, Derrick J Rossi

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. International journal of molecular sciences · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. iScience · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Brian S GarrisonProgram in Cellular and Molecular Medicine, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.
Adrian P RybakProgram in Cellular and Molecular Medicine, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.
Isabel BeermanNational Institute on Aging, National Institutes of Health, Baltimore, MD.
Balthasar HeestersDivision of Immunology, Harvard Medical School, Boston, MA.
Francois E MercierDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA.
David T ScaddenDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA.
David BryderDivision of Molecular Hematology, Lund Stem Cell Center, Lund University, Lund, Sweden.
Roland BaronDepartment of Medicine, Harvard Medical School, Boston, MA.
Derrick J RossiProgram in Cellular and Molecular Medicine, Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA.
Harvard Stem Cell Institute · USHarvard University · USLund University · SEMassachusetts General Hospital · USNational Institutes of Health · US

Funding

Progenitor Cell Biology Consortium Administrative Coordinating CenterU01HL099997 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI TERRIN, MICHAEL L · 2009 to 2015
$29.9M
Preclinical development of gene-edited human hematopoietic stem cellsU19HL129903 · NHLBI · HARVARD UNIVERSITY · PI SCADDEN, DAVID T · 2015 to 2019
$11.5M
Integrating lipid genotyes and phenotypes in iPS derived hepatocytes/adipocytesU01HL107440 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI COWAN, CHAD ALBERT, DEO, RAHUL CHANDRAKANT · 2011 to 2015
$9.0M
Humanized Mouse Avatars for T1DUC4DK104218 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BREHM, MICHAEL ALLEN, DALEY, GEORGE Q · 2014 to 2014
$4.1M
Role of Zfp521 in bone formation and anabolic responsesR01AR057769 · NIAMS · HARVARD MEDICAL SCHOOL · PI BARON, ROLAND E · 2010 to 2014
$3.0M
Reprogramming committed blood cells to a hematopoietic stem cell fateR01HL107630 · NHLBI · IMMUNE DISEASE INSTITUTE, INC. · PI ROSSI, DERRICK J. · 2011 to 2015
$2.5M
Characterization of hematopoietic stem cell (HSC) and progenitor cell aging, identification of candidate age-regulated genes as targets for therapeutic interventionZIAAG000992 · NIA · NATIONAL INSTITUTE ON AGING · PI BEERMAN, ISABEL · 2017 to 2025
$1.7M
NHLBI NIH HHS R01 HL107630NHLBI NIH HHS U01 HL099997NHLBI NIH HHS U01 HL107440NHLBI NIH HHS U19 HL129903NIAMS NIH HHS R01 AR057769NIDDK NIH HHS UC4 DK104218
6 · The paper itself

Abstract

The concept that tumor-initiating cells can co-opt the self-renewal program of endogenous stem cells as a means of enforcing their unlimited proliferative potential is widely accepted, yet identification of specific factors that regulate self-renewal of normal and cancer stem cells remains limited. Using a comparative transcriptomic approach, we identify

Indexed as

Cell ProliferationAnimalsCell Line, TumorDNA-Binding ProteinsHematopoietic Stem CellsHistone-Lysine N-MethyltransferaseHumansMiceMice, KnockoutMyeloid-Lymphoid Leukemia ProteinNeoplasms, ExperimentalNuclear ProteinsPrecursor Cell Lymphoblastic Leukemia-LymphomaTranscription FactorsTranslocation, GeneticDNA-Binding ProteinsEvi3 protein, mouseHistone-Lysine N-MethyltransferaseKMT2A protein, humanKmt2a protein, mouseMllt3 protein, mouseMyeloid-Lymphoid Leukemia ProteinNuclear ProteinsTranscription Factorszinc finger protein 521, human

Identifiers

PMID28615219
PMCPMC5542850
OpenAlexW2626086726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.